Blood Volume Analysis and Cardiorenal Syndrome: From Bench to Bedside [0.03%]
血液容量分析与心肾综合征：从实验研究到临床实践
John Lynn Jefferies,Cynthia Ann Stavish,Marc A Silver et al.
John Lynn Jefferies et al.
Background: This review delves into the intricate landscape of cardiorenal syndrome (CRS) and highlights the pivotal role of blood volume analysis (BVA) in improving patient care and outcomes. ...
Sodium-Glucose Cotransporter-2 Inhibitors Use in Patients with Reduced Kidney Function Hospitalized for Fluid Overload and Heart Failure: An Observational Study [0.03%]
肾功能减退的心衰住院患者使用钠-葡萄糖协同转运蛋白-2抑制剂的疗效观察研究
Shi Yun Tan,Lourdes Ducusin Galang,Ee Won Leong et al.
Shi Yun Tan et al.
Introduction: Sodium-glucose cotransporter-2 inhibitors (SGLT2is) are recommended in kidney disease and heart failure to reduce adverse clinical outcomes, but utilization can vary. To understand potential gaps in clinical...
Observational Study
Cardiorenal medicine. 2024;14(1):443-453. DOI:10.1159/000540493 2024
Thomas M Beaver,Bhagwan Dass,Ami M Patel et al.
Thomas M Beaver et al.
Background: Cardiac surgery-associated acute kidney injury (CS-AKI) remains a vexing issue. Clinical trials for the prevention of CS-AKI have been disappointing despite enormous initial enthusiasm based on experimental da...
Periostin Predicts All-Cause Mortality in Male but Not Female End-Stage Renal Disease Patients on Hemodialysis [0.03%]
periostin可预测终末期肾病男性但不能预测女性血液透析患者的全因死亡率
Xitong Li,Yvonne Liu,Johann-Georg Hocher et al.
Xitong Li et al.
Introduction: Periostin is a matricellular protein. Elevated serum concentrations of periostin have been reported in patients with various cardiovascular diseases, including heart failure. Patients with end-stage renal di...
Increased risk of end-stage kidney disease in patients with chronic kidney disease and heart failure with reduced ejection fraction [0.03%]
射血分数降低的心力衰竭患者慢性肾脏病终末期肾病的风险增加
Saif Al-Chalabi,Mathew Poulose,Sharmilee Rengarajan et al.
Saif Al-Chalabi et al.
Introduction: The prevalence of heart failure (HF) is more common in people with advanced non-dialysis chronic kidney disease (ND-CKD). It is well known that HF with reduced ejection fraction (HFrEF) is associated with a ...
Long-Term Renal Function with Cardiac Contractility Modulation Therapy [0.03%]
长期心脏收缩力调制治疗的肾脏功能和心脏收缩力的影响
Goekhan Yuecel,Babak Yazdani,Kristin Schreiner et al.
Goekhan Yuecel et al.
Introduction: Cardiac implantable electrical devices are able to affect kidney function through hemodynamic improvements. The cardiac contractility modulation (CCM) is a device-based therapy option for patients with sympt...
Observational Study
Cardiorenal medicine. 2024;14(1):385-396. DOI:10.1159/000539259 2024
Impact of Chronic Kidney Disease on the Outcomes of Patients Undergoing Percutaneous Left Atrial Appendage Occlusion: Insights from a Large National Database [0.03%]
慢性肾脏疾病对经皮左心耳封堵术患者结局影响的研究：来自大型国家数据库的启示
Frederick Berro Rivera,Sung Whoy Cha,Akanimo Antia et al.
Frederick Berro Rivera et al.
Background: Studies exploring the effectiveness and safety of percutaneous left atrial appendage occlusion (pLAAO) in patients with chronic kidney disease (CKD) are limited. ...
Portal Vein Doppler Is a Sensitive Marker for Evaluating Venous Congestion in End-Stage Kidney Disease [0.03%]
门脉多普勒是评估终末期肾脏疾病患者静脉瘀血的一项敏感指标
Melinda M Tonelli,Eduardo R Argaiz,Joseph R Pare et al.
Melinda M Tonelli et al.
Introduction: Determining ultrafiltration volume in patients undergoing intermittent hemodialysis (IHD) is an essential component in the assessment and management of volume status. Venous excess ultrasound (VExUS) is a no...
Observational Study
Cardiorenal medicine. 2024;14(1):375-384. DOI:10.1159/000539901 2024
Perspectives in Managing Kidney Disease and Atherosclerotic Cardiovascular Disease [0.03%]
肾病和动脉粥样硬化性心血管疾病的管理展望
Tarlan Namvar,Matthew A Cavender,Eden Miller et al.
Tarlan Namvar et al.
Introduction: Chronic kidney disease (CKD) and atherosclerotic cardiovascular disease (ASCVD) share a complex and dependent link with each other and other cardiometabolic conditions. Currently, there is insufficient data ...
Unlocking the Potential of VExUS in Assessing Venous Congestion: The Art of Doing It Right [0.03%]
解锁VExUS在评估静脉淤血中的潜力：正确操作的艺术
Abhilash Koratala,Gregorio Romero-González,Hatem Soliman-Aboumarie et al.
Abhilash Koratala et al.
Background: Congestion, marked by elevated cardiac filling pressures and their repercussions, is a contributing factor to morbidity and mortality in heart failure and critical illness. Relying on traditional methods for b...